SEARCH
WHO Backs Merck's Antiviral Pill For High-Risk Covid Patients But Finds Regeneron's Antibody C - 1br
1BN
2022-03-03
Views
2
Description
Share / Embed
Download This Video
Report
The WHO panel is also evaluating data for Pfizer's antiviral pill, paxlovid, and a widely available antidepressant, fluvoxamine, to treat Covid-19.
VIEW MORE : https://bit.ly/1breakingnews
Show more
Share This Video
facebook
google
twitter
linkedin
email
Video Link
Embed Video
<iframe width="600" height="350" src="https://dailytv.net//embed/x88i41k" frameborder="0" allowfullscreen></iframe>
Preview Player
Download
Report form
Reason
Your Email address
Submit
RELATED VIDEOS
02:04
The UK approves Merck's COVID-19 antiviral pill, calling it a world first - 1breakingnews.com
01:34
France orders 50,000 doses of Merck's Covid-19 antiviral pill
01:30
FDA Advisers Narrowly Endorse Merck’s COVID Antiviral Pill
01:30
Merck's Covid Antiviral Pill Approved by UK Regulator
05:35
White House working to make Pfizer's Covid-19 antiviral pill more 'widely available' - 1breakingnews
03:23
Anti-COVID pill molnupiravir approved for use in the UK in world first for Merck antiviral
00:43
Merck Double Downs COVID-19 Antiviral Pill Production
02:21
Britain is first to approve Merck COVID-19 antiviral pill
02:54
WHO Endorses Pfizer's Antiviral Pill Paxlovid For High-Risk Covid Patients But Says Benefits ' - 1br
02:36
Interim analysis shows merck's antiviral molnupiravir reduces risk of hospitalization or death by 50%
01:15
Malaysia looking at other antivirals besides Merck's Molnupiravir, says Khairy
01:48
EUA for anti-Covid pill is likely to be sanctioned within days | Merck's Molnupiravir |Oneindia News
